drugset

drugset / Trial / NCT00373568

Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis

NCT00373568 ↗

Phase 1/2 Completed 25 enrolled AB Foundation

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Miltefosine (longer course) will be used to try to improve the cure rate of mucosal leishmaniasis

Timeline

Start: 2005-04
Primary completion: —
Completion: 2007-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Miltefosine	Small molecule	2.5 mg/kg	—

Indications